新闻稿

Illumina to Announce First Quarter 2017 Financial Results on Tuesday, April 25, 2017

SAN DIEGO--(BUSINESS WIRE)--Apr. 11, 2017-- Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for first quarter 2017 following the close of market on Tuesday, April 25, 2017.

On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time), Francis deSouza, President and Chief Executive Officer; Marc Stapley, Executive Vice President and Chief Administrative Officer; and Sam Samad, Senior Vice President and Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Tuesday, April 25, 2017. Interested parties may listen to the call by dialing 888.771.4371 (passcode: 44658255), or if outside North America by dialing +1.847.585.4405 (passcode: 44658255). Individuals may access the live teleconference in the Investor Relations section of Illumina’s web site under the “company” tab at www.illumina.com.

A replay of the conference call will be available from 4:30 pm Pacific Time (7:30 pm Eastern Time) on April 25, 2017 through May 2, 2017 by dialing 888.843.7419 (passcode: 44658255), or if outside North America by dialing +1.630.652.3042 (passcode: 44658255).

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.

Source: Illumina, Inc.

Illumina, Inc.
Investors:
Rebecca Chambers, 858.255.5243
ir@illumina.com
or
Media:
Eric Endicott, 858.882.6822
pr@illumina.com

Recent Articles

Admera Health使用NovaSeq™ X Plus测序仪扩展检测能力
Admera Health使用NovaSeq™ X Plus测序仪扩展检测能力
因美纳员工如何挺身而出、伸出援手、回馈社会
因美纳员工如何挺身而出、伸出援手、回馈社会
因美纳职业发展:在新兴市场拓展NGS的应用
因美纳职业发展:在新兴市场拓展NGS的应用